President Trump signed the sweeping opioid legislation into law Wednesday afternoon at a White House ceremony. It was a very well attended event, including Cabinet members, legislators, leadership from our field and business leaders, especially from the large pharmacy retail groups.
Mrs. Trump also made opening remarks reflecting […]Read More »
ABSTRACT SUBMISSION Deadline EXTENDED to January 25, 2019!
EARLY REGISTRATION DEADLINE: January 31, 2019
For more information, please click HERE.Read More »
Phone Calls of Support for Medicare Part B Legislation : This is our last chance to influence the Senate/House Vote with regard to the Medicare coverage for eligible patients in OTPs. Please follow the directions in this link https://www.opioidrecovery.org/actnow/ and call your […]Read More »
Some quick FACTS about the dangers of Fentanyl:
Fentanyl has been manufactured by a number of pharmaceutical companies for the management of severe, chronic pain. There are just over one […]
We are pleased to announce the release of the End of the Year AATOD Newsletter (Special Edition). Please click HERE to view the full version of the AATOD Newsletter (PDF).
In this special issue, you will read about the following topics written by several of our Board members and […]Read More »
AATOD will produced a third and final Medicaid webinar for 2017. This webinar was designed to increase interest in utilizing Medicaid and other third-party reimbursement for OTPs. Our ultimate goal was to have every state in the United States, providing Medicaid reimbursement for Medicaid-eligible patients seeking care and being treated […]Read More »
This Fact Sheet is intended to separate anecdote and ideology from evidence and fact. AATOD hopes that this Fact Sheet will guide representatives, especially in the justice system, to better understand how federally approved medications are best used in treating opioid use disorder. We welcome all feedback. Click HERE […]Read More »
As many of our associates know, OTPs are expanding throughout the United States, responding to the increasing need to access comprehensive treatment, which is the hallmark of well-run opioid treatment programs. The AATOD Board of Directors agreed to release recommendations to the field for siting new opioid treatment programs throughout […]Read More »
The New York State Office of Alcoholism and Substance Abuse Services (OASAS) and the Coalition of Medication-Assisted Treatment Providers and Advocates of New York State (COMPA) are pleased to host the AATOD Conference which begins tomorrow, Saturday March 10 through Wednesday, March 14 at the New York Marriott Marquis Hotel […]Read More »
One great source is this extensive interview done by William L. White, Emeritus Senior Research Consultant at Chestnut Health Systems: “Elevating the Quality of Medication-Assisted Treatment of Opioid Addiction: An Interview with Mark Parrino, M.P.A.” We hope this interview will add more perspective to AATOD’s timeline.Read More »